19-45001684-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006509.4(RELB):āc.105A>Cā(p.Leu35Phe) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000199 in 1,511,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006509.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RELB | NM_006509.4 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant | 1/12 | ENST00000221452.13 | |
RELB | NM_001411087.1 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant | 1/11 | ||
RELB | XM_005259128.3 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant | 1/11 | ||
RELB | XM_047439189.1 | c.-360A>C | splice_region_variant, 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RELB | ENST00000221452.13 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant | 1/12 | 1 | NM_006509.4 | P2 | |
RELB | ENST00000505236.2 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant | 1/11 | 5 | A2 | ||
RELB | ENST00000509480.5 | c.105A>C | p.Leu35Phe | missense_variant, splice_region_variant, NMD_transcript_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151780Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000860 AC: 1AN: 116322Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64192
GnomAD4 exome AF: 7.36e-7 AC: 1AN: 1359428Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 670670
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151780Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74130
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RELB-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.009%). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 35 of the RELB protein (p.Leu35Phe). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at